Literature DB >> 7855212

Low dose of 1,3-di(2-tolyl)guanidine (DTG) attenuates MK-801-induced spatial working memory impairment in mice.

T Maurice1, M Hiramatsu, J Itoh, T Kameyama, T Hasegawa, T Nabeshima.   

Abstract

MK-801 (30-100 micrograms/kg, SC) impaired spontaneous alternation behavior of mice, a behavior related to the spatial working memory. 1,3-Di-(2-tolyl)guanidine (DTG), (+)-pentazocine and (+)-SKF 10,047 (100 micrograms/kg, SC), putative sigma agonists, administered 10 min before MK-801, partially but significantly reversed the impairment, without affecting the concomitant hyperlocomotion. The antagonizing effects by DTG were prevented by BMY-14802 (5 mg/kg, IP), a purported sigma antagonist. These findings suggest that, at low doses, sigma ligands may modulate the N-methyl-D-aspartate dependent memory processes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7855212     DOI: 10.1007/bf02249345

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  7 in total

1.  NMDA receptor antagonists can enhance or impair learning performance in animals.

Authors:  C Mondadori; L Weiskrantz; H Buerki; F Petschke; G E Fagg
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

2.  N-methyl-D-aspartate-induced neuronal activation is selectively modulated by sigma receptors.

Authors:  F P Monnet; G Debonnel; J L Junien; C De Montigny
Journal:  Eur J Pharmacol       Date:  1990-04-25       Impact factor: 4.432

3.  Excitatory amino acid antagonists and memory: effect of drugs acting at N-methyl-D-aspartate receptors in learning and memory tasks.

Authors:  J Parada-Turska; W A Turski
Journal:  Neuropharmacology       Date:  1990-12       Impact factor: 5.250

4.  Dynorphin A-(1-13) potently prevents memory dysfunctions induced by transient cerebral ischemia in mice.

Authors:  J Itoh; M Ukai; T Kameyama
Journal:  Eur J Pharmacol       Date:  1993-03-30       Impact factor: 4.432

5.  The sigma receptor ligand 1,3-di-(2-tolyl)guanidine in animal models of schizophrenia.

Authors:  N G Rückert; W J Schmidt
Journal:  Eur J Pharmacol       Date:  1993-03-23       Impact factor: 4.432

6.  In vivo electrophysiological evidence for a selective modulation of N-methyl-D-aspartate-induced neuronal activation in rat CA3 dorsal hippocampus by sigma ligands.

Authors:  F P Monnet; G Debonnel; C de Montigny
Journal:  J Pharmacol Exp Ther       Date:  1992-04       Impact factor: 4.030

7.  Attenuation of scopolamine-induced impairment of spontaneous alteration behaviour by antagonist but not inverse agonist and agonist beta-carbolines.

Authors:  M Sarter; G Bodewitz; D N Stephens
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

  7 in total
  5 in total

1.  Involvement of glutamatergic and dopaminergic systems in the reactivity of mice to spatial and non-spatial change.

Authors:  P Roullet; A Mele; M Ammassari-Teule
Journal:  Psychopharmacology (Berl)       Date:  1996-07       Impact factor: 4.530

2.  The attenuation of learning impairments induced after exposure to CO or trimethyltin in mice by sigma (sigma) receptor ligands involves both sigma1 and sigma2 sites.

Authors:  T Maurice; V L Phan; Y Noda; K Yamada; A Privat; T Nabeshima
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

3.  Purification, molecular cloning, and expression of the mammalian sigma1-binding site.

Authors:  M Hanner; F F Moebius; A Flandorfer; H G Knaus; J Striessnig; E Kempner; H Glossmann
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

4.  Sigma-1 receptor knockout mice display a depressive-like phenotype.

Authors:  Valentina Sabino; Pietro Cottone; Sarah L Parylak; Luca Steardo; Eric P Zorrilla
Journal:  Behav Brain Res       Date:  2008-11-30       Impact factor: 3.332

Review 5.  Revisiting the sigma-1 receptor as a biological target to treat affective and cognitive disorders.

Authors:  Kinga Sałaciak; Karolina Pytka
Journal:  Neurosci Biobehav Rev       Date:  2021-11-01       Impact factor: 8.989

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.